Revelation Biosciences (REVB) to Release Quarterly Earnings on Friday

Revelation Biosciences (NASDAQ:REVB) is expected to be issuing its quarterly earnings data before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($3.20) per share for the quarter.

Revelation Biosciences Price Performance

Shares of Revelation Biosciences stock opened at $2.88 on Wednesday. Revelation Biosciences has a 1-year low of $2.36 and a 1-year high of $60.80. The stock has a market cap of $2.61 million, a P/E ratio of -0.01 and a beta of 0.17. The stock’s 50 day simple moving average is $4.09 and its 200-day simple moving average is $8.74.

About Revelation Biosciences

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.